Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C

NCT00203606 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT00203606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00203606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C
Lead sponsor
University of Calgary
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2004
Completion date
August 31, 2011
Enrollment
66 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c